MannKind Corporation (MNKD) earnings
MNKD earnings moved a median of -0.49% by the close. Quarterly and annual MNKD reports and results, each read against the price at its own news timestamp. Back to the MNKD overview →
18 measured MNKD earnings events.
Where these MNKD earnings landedvs 18 measured MNKD earnings reactions
| Middle 50% of MNKD earnings reactions | -5.51% to +2.10% |
|---|---|
| Median reaction (to close) | -0.49% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 MNKD earnings events with a measured close landed between -5.51% and +2.10%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q MANNKIND CORP For: Jun 30 | SEC filing · Form 10-Q | +0.79% | +2.10% | |
| MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +0.79% | +2.10% | |
| Form 10-Q MANNKIND CORP For: Mar 31 | SEC filing · Form 10-Q | +7.70% | +7.25% | |
| MannKind Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | +7.70% | +7.25% | |
| MannKind to Report First Quarter 2026 Financial Results on May 6, 2026 | Press release | +2.00% | +2.91% | |
| Form 10-K MANNKIND CORP For: Dec 31 | SEC filing · Form 10-K | -6.22% | -12.43% | |
| Form 10-Q MANNKIND CORP For: Sep 30 | SEC filing · Form 10-Q | +1.09% | +1.68% | |
| MannKind Corporation Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +1.09% | +1.68% | |
| Form 10-Q MANNKIND CORP For: Jun 30 | SEC filing · Form 10-Q | -2.59% | -5.59% | |
| MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update | Press release | -2.59% | -5.59% | |
| Form 10-Q MANNKIND CORP For: Mar 31 | SEC filing · Form 10-Q | -4.79% | -1.49% | |
| MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | -4.79% | -1.49% | |
| Form 10-K MANNKIND CORP For: Dec 31 | SEC filing · Form 10-K | -1.10% | -4.04% | |
| Form 10-Q MANNKIND CORP For: Sep 30 | SEC filing · Form 10-Q | +2.23% | +5.68% | |
| Form 10-Q MANNKIND CORP For: Jun 30 | SEC filing · Form 10-Q | -3.06% | -9.73% | |
| Form 10-Q MANNKIND CORP For: Mar 31 | SEC filing · Form 10-Q | -4.18% | -5.28% | |
| Form 10-K MANNKIND CORP For: Dec 31 | SEC filing · Form 10-K | +7.05% | +0.51% | |
| Form 10-Q MANNKIND CORP For: Sep 30 | SEC filing · Form 10-Q | -3.98% | -9.20% |
Keep exploring
More MNKD: analyst actions → · SEC filings → · MNKD overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cellect Biotechnology Ltd. - American Depositary Shares (APOP) | 337 | -0.42% | 35% |
| Cardinal Health, Inc. (CAH) | 335 | +0.02% | 52% |
| Protagonist Therapeutics, Inc. (PTGX) | 335 | -0.24% | 43% |
| MYOS RENS TECH INC COMMON (MYOS) | 334 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.